Japan· JP-3399004M2022
イコサペント酸エチル
A medicinal product containing イコサペント酸エチル, registered in Japan by 持田製薬, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- イコサペント酸エチル
- Manufacturer
- 持田製薬
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
イコサペント酸エチル in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesIcosapentBryant Ranch Prepack
- CzechiaVAZKEPARecordati Industria Chimica e Farmaceutica S.p.A., Milano
- FinlandVazkepaRecordati Industria Chimica e Farmaceutica S.p.A.
- SwitzerlandVazkepa 998 mg, WeichkapselnRECORDATI AG
- ItalyVAZKEPA*120 cps molli 998 mg flaconeAMARIN PHARMAC IRELAND LIMITED
- NetherlandsVazkepa 998 mg zachte capsulesRecordati Industria Chimica e Farmaceutica S.p.A.
- NorwayVazkepaRecordati Industria Chimica e Farmaceutica S.p.A.
- SwedenVazkepa 998 mg Kapsel, mjukRecordati Industria Chimica e Farmaceutica S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vazkepa
- Liechtenstein · Vazkepa
- Norway · Vazkepa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fddcd0c8-37e0-454e-b833-ff558c6187d1 GET /v1/drugs/fddcd0c8-37e0-454e-b833-ff558c6187d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "３００ｍｇ１包",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "3399004M2022",
"category": "内用薬",
"price_yen": 19.4,
"generic_name": "イコサペント酸エチル",
"product_name_jp": null,
"therapeutic_class": "3399",
"transitional_expiry": null
}See everything about イコサペント酸エチル.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.